Is CEO pay linked to drug prices? Curious investors failed their campaign to find out

With pharma CEOs pulling in millions of dollars per year, some Big Pharma investors wanted to know whether drug prices are rising because executives personally benefit. But when they put that question up for a vote, their fellow shareholders turned them away.